Persistent hot flashes may lead to increased risk of breast cancer

Studies examining the association between vasomotor symptoms (VMS) and breast cancer are not new, but results have been inconsistent. A new larger-scale study concludes that women participating in the Women's Health Initiative (WHI) trials who had persistent VMS are more likely to be diagnosed with breast cancer than women who never experienced VMS.

from Women's Health News -- ScienceDaily http://bit.ly/2Syxt4B

Persistent hot flashes may lead to increased risk of breast cancer

Studies examining the association between vasomotor symptoms (VMS) and breast cancer are not new, but results have been inconsistent. A new larger-scale study concludes that women participating in the Women's Health Initiative (WHI) trials who had persistent VMS are more likely to be diagnosed with breast cancer than women who never experienced VMS.

from Women's Health News -- ScienceDaily http://bit.ly/2Syxt4B

How to better reach men for HIV testing: A randomized trial on incentives for self-testing

Providing pregnant women with HIV self-testing kits to pass along to their male partners can boost the partners' rate of HIV testing and entry into care, according to a new research.

from Sexual Health News -- ScienceDaily http://bit.ly/2F4gtzy
via IFTTT

Tumors backfire on chemotherapy

Chemotherapy is an effective treatment for breast cancer, yet some patients develop metastasis in spite of it. Researchers have now discovered that chemotherapy-treated mammary tumors produce small vesicles that may help them spread to other organs.

from Women's Health News -- ScienceDaily http://bit.ly/2ThgELE

Tumors backfire on chemotherapy

Chemotherapy is an effective treatment for breast cancer, yet some patients develop metastasis in spite of it. Researchers have now discovered that chemotherapy-treated mammary tumors produce small vesicles that may help them spread to other organs.

from Women's Health News -- ScienceDaily http://bit.ly/2ThgELE

Tumors backfire on chemotherapy

Chemotherapy is an effective treatment for breast cancer, yet some patients develop metastasis in spite of it. Researchers have now discovered that chemotherapy-treated mammary tumors produce small vesicles that may help them spread to other organs.

from Breast Cancer News -- ScienceDaily http://bit.ly/2ThgELE

Breaking down AGEs: Insight into how lifestyle drives ER-positive breast cancer

Consumption of processed foods high in sugar and fat increase levels of advanced glycation end products (AGEs). Researchers report that AGE levels are higher in patients with estrogen receptor (ER)-positive than ER-negative breast cancer. Addition of AGEs caused breast cancer cells, whose growth had previously been controlled by tamoxifen, to begin to grow again. This suggests that patients with high AGEs may be less likely to respond to tamoxifen treatment.

from Women's Health News -- ScienceDaily http://bit.ly/2VjkXIj

Breaking down AGEs: Insight into how lifestyle drives ER-positive breast cancer

Consumption of processed foods high in sugar and fat increase levels of advanced glycation end products (AGEs). Researchers report that AGE levels are higher in patients with estrogen receptor (ER)-positive than ER-negative breast cancer. Addition of AGEs caused breast cancer cells, whose growth had previously been controlled by tamoxifen, to begin to grow again. This suggests that patients with high AGEs may be less likely to respond to tamoxifen treatment.

from Women's Health News -- ScienceDaily http://bit.ly/2VjkXIj

Breaking down AGEs: Insight into how lifestyle drives ER-positive breast cancer

Consumption of processed foods high in sugar and fat increase levels of advanced glycation end products (AGEs). Researchers report that AGE levels are higher in patients with estrogen receptor (ER)-positive than ER-negative breast cancer. Addition of AGEs caused breast cancer cells, whose growth had previously been controlled by tamoxifen, to begin to grow again. This suggests that patients with high AGEs may be less likely to respond to tamoxifen treatment.

from Breast Cancer News -- ScienceDaily http://bit.ly/2VjkXIj

Breast cancer drugs could help treat resistant lung cancers

A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, a new study suggests. The research found that lung tumors in mice caused by mutations in a gene called EGFR shrunk significantly when a certain protein was blocked.

from Breast Cancer News -- ScienceDaily http://bit.ly/2RhCVvA